Sertraline (Zoloft) is the preferred SSRI for PTSD treatment
Both sertraline and paroxetine have FDA approval for PTSD, but sertraline should be your first choice due to its superior safety profile, particularly regarding suicidality risk and discontinuation syndrome. 1, 2
FDA-Approved Options
Only two SSRIs have FDA indication specifically for PTSD treatment 2:
Why Sertraline Over Paroxetine
Safety Concerns with Paroxetine
Paroxetine carries an increased risk of suicidal thinking or behavior compared to other SSRIs 3. This is a critical consideration given that PTSD patients already have elevated suicide risk. Additionally, paroxetine is notably associated with:
- More severe discontinuation syndrome - characterized by dizziness, electric shock-like sensations, nausea, and agitation when doses are missed or the medication is stopped 3
- Higher rates of sexual dysfunction compared to sertraline, fluoxetine, fluvoxamine, and nefazodone 4
Sertraline's Advantages
Sertraline demonstrates:
- Equivalent efficacy to paroxetine for all PTSD symptom clusters 5, 6, 7
- Better tolerability profile with less severe discontinuation effects 3
- Lower propensity for drug-drug interactions via CYP2D6 metabolism 3
- Proven effectiveness in both combat veterans and civilian trauma populations 7
Current Guideline Recommendations
The 2023 VA/DoD Clinical Practice Guideline makes a strong recommendation for either paroxetine, sertraline, or venlafaxine when pharmacotherapy is chosen 8. However, this guideline emphasizes that trauma-focused psychotherapy should be prioritized over medication as first-line treatment 8, 9.
Practical Prescribing Algorithm
When choosing between these two FDA-approved SSRIs:
- Start with sertraline in most patients due to better safety profile
- Consider paroxetine only if:
- Patient has failed sertraline trial
- Specific contraindications to sertraline exist
- Patient has prior positive response to paroxetine
Dosing approach:
- Begin with subtherapeutic "test dose" to assess for initial anxiety/agitation 3
- Titrate slowly at 1-2 week intervals for sertraline 3
- Continue for minimum 8 weeks to assess response 5
- Maintain treatment for at least 12 months, often 24+ months given relapse risk 5
Critical Monitoring Points
Within first 1-2 weeks and after dose changes 4, 1:
- Suicidal ideation or behavior (especially first 1-2 months)
- Behavioral activation, agitation, or irritability
- Emergence of manic symptoms
Ongoing monitoring:
- Sexual dysfunction (may require dose adjustment or switch)
- Bleeding risk if on anticoagulants or NSAIDs 1
- Hyponatremia, particularly in elderly patients 1
Common Pitfall to Avoid
Do not stop either medication abruptly. Both sertraline and paroxetine are associated with discontinuation syndrome, though paroxetine's is more severe 3. Taper gradually when discontinuing to prevent withdrawal symptoms including dizziness, electric shock sensations, and mood changes 1.
Combination with Psychotherapy
Strongly consider combining medication with trauma-focused psychotherapy (prolonged exposure, cognitive processing therapy, or EMDR) rather than using medication alone 8, 9. The VA/DoD guideline gives psychotherapy alone a stronger recommendation than pharmacotherapy for PTSD treatment 8.